The Centers for Medicare and Medicaid Services (CMS) finalized a 2.3% increase to the national standardized operating amount for hospitals that successfully participate in the Hospital Inpatient Quality Reporting Program and are meaningful electronic health record users effective October 1, 2026. CMS estimates that Inpatient Prospective Payment System (IPPS) payment and policy changes will increase acute-care hospital payments by approximately $2.1 billion; including additional payments associated with new medical technologies, the estimated increase is approximately $2.9 billion. The headline increase, however, will not translate uniformly across hospitals, specific to wage index, case mix, quality performance, uncompensated care, outliers, and other hospital-specific factors that will determine the actual result.
Key Takeaways
1. Payment Growth Remains Positive —But Performance Requirements Matter
The 2.3% update reflects a projected 3.2% hospital market-basket increase reduced by a 0.9 percentage-point productivity adjustment. However, hospitals that fail to submit quality data but are meaningful EHR users receive a smaller update at 1.5% whereas submitting quality data and not being a meaningful EHR user represents a −0.1% reduction and a further reduction of −0.9% if both requirements are missed. Finance teams should model the corrected impact files at the provider level rather than treating the national increase as a budget assumption.
2. MS-DRG Changes – Require Immediate Coding & Revenue-Cycle Readiness
For discharges on or after October 1, 2026, hospitals must use the Federal Fiscal Year (FFY) 2027 MS-DRG Grouper and Medicare Code Editor Version 44.0.
CMS has deleted 18 MS-DRGs and created 14 new MS-DRG’s, bringing the total to 768. Coding, clinical documentation integrity, chargemaster, utilization review, managed-care modeling, and billing teams should validate grouper logic, test high-volume service lines, and review changes affecting the post-acute transfer policy and device-credit payment reductions.
3. Episode-Based Payment is Expanding
CMS finalized a nationwide expansion of the Comprehensive Care for Joint Replacement model, known as CJR-X. The model will cover hip, knee, and ankle replacements performed in inpatient and hospital outpatient settings and will begin January 1, 2028. CMS also refined the Transforming Episode Accountability Model, including eligible spinal-fusion episodes, attribution and quality methodologies, target-price calculations, and normalization factors. Organizations should align clinical pathways, physician engagement, post-acute networks, quality data, and episode-level financial analytics well before implementation.
4. Teaching Hospitals Face New GME Test
CMS revised the criteria for determining whether a residency program is “new” for Medicare Graduate Medical Education (GME) purposes. In general, the program must receive initial accreditation, and at least 90% of the individual residents participating during the five-year cap-building period must have no prior training in the same specialty. The rule also addresses nondiscrimination requirements for residency and nursing/allied health education programs, Medicare Advantage payment calculations for nursing and allied health education, and redistribution of resident cap slots following teaching-hospital closures. Teaching hospitals should review program structures, resident histories, affiliation agreements, and documentation supporting cap treatment.
5. New Technology Add On Payments (NTAP)
CMS expects additional payments for cases involving new medical technologies to rise by approximately $779 million in FFY 2027. The agency continued NTAP status for 41 technologies, discontinued payments for 13, approved three of 15 applications under the traditional pathway, and approved 16 technologies through the alternative pathway for qualifying breakthrough devices. Hospitals should use CMS’s FFY 2027 MAC Implementation File 8 to identify newly approved, continuing, and discontinued technologies and to confirm the applicable coding and maximum add-on payment for each product.
The rule also changes the future application landscape. Beginning with FFY 2028 applications, CMS will eliminate the alternative NTAP pathways, subject to limited transition provisions, making the traditional criteria the principal route to approval. Technologies generally will need to demonstrate that they are new, that the existing MS-DRG payment is inadequate, and that they represent a substantial clinical improvement. For hospitals, NTAP readiness requires more than recognizing an eligible product: clinical, coding, pharmacy or supply chain, chargemaster, utilization management, and claims teams must align documentation and coding so qualifying cases are identified and paid correctly.
CMS’s final FFY 2027 rule delivers a positive national payment update, but the more consequential story is operational changes such as the revised MS-DRGs, stricter alignment between quality and payment, new GME criteria, and wider mandatory episode accountability. Hospitals that combine reimbursement modeling with coding validation and cross-functional implementation will be best positioned to capture payment accurately and manage risk.
SunStone Consulting offers comprehensive Reimbursement, Revenue Integrity and Revenue Cycle Management Solutions specifically geared to assisting providers manage the ever-changing regulatory environment. For more information about the final Rule or any questions regarding our solutions, please contact Brian Barbera, Senior Principal, at brianbarbera@sunstoneconsulting.com or Vonda Moon, Senior Principal at vondamoon@sunstoneconsulting.com.